Results 291 to 300 of about 1,389,478 (387)

PULMONARY EMBOLISM

Annals of Surgery, 1940
openaire   +3 more sources

Deep Vein Thrombosis in Critically Ill Patients with COVID‐19 Pneumonia

Journal of Ultrasound in Medicine, EarlyView.
Objectives The risk of major venous thromboembolism (VTE) among patients with COVID‐19 is high but varies with disease severity. Estimate the incidence of lower extremity deep venous thrombosis (DVT) in critically ill hospitalized patients with COVID‐19, validate the Wells score for DVT diagnosis, and determine patients' prognosis.
Clévio Cezar da Fonseca, Hugo Perazzo, Sandra Wagner Cardoso, Isabel Cristina Ferreira Tavares, Maria Pia Diniz Ribeiro, Rodrigo de Carvalho Moreira, Lara Esteves Coelho, Emília Moreira Jalil, André Miguel Japiassú, Elias Pimentel Gouvêa, Estevão Portela Nunes, Hugo Boechat Andrade, Luciano Barros Gouvêa, Marcel Treptow Ferreira, Pedro Mendes Azambuja‐Rodrigues, Ronaldo Ismerio Moreira, Kim Mattos Geraldo, Lucilene Araújo de Freitas, Vinicius Velleda Pacheco, Beatriz Gilda Jegerhorn Grinsztein, Pedro Emmanuel Alvarenga Americano do Brasil   +20 more
wiley   +1 more source

The dose of alteplase in massive pulmonary embolism: should it be individualized? [PDF]

Acute Crit Care
Garg SK.
europepmc   +1 more source

Diagnosis of acute Pulmonary Embolism.

Hämostaseologie, 2018
M. Righini, H. Robert-Ebadi
semanticscholar   +1 more source

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Baricitinib is a selective Janus kinase (JAK)1/JAK2 inhibitor approved in more than 70 countries for the treatment of moderate‐to‐severe atopic dermatitis (AD) in adults, and in over 30 countries for adolescents and children from age 2 years with moderate‐to‐severe AD, who are candidates for systemic therapy.
Antonio Costanzo, Antonio Torrelo, Eric L. Simpson, Marjolein De Bruin‐Weller, Diamant Thaçi, Norito Katoh, Silvia Sabatino, Andrew Buchanan, Kasia Morawska, Samuel Ogwu, Karen Denning, Jonathan I. Silverberg   +11 more
wiley   +1 more source

Prevalence and effects of pulmonary embolism on hospital outcomes among COVID-19 patients. [PDF]

BMC Res Notes
Nijhawan A, Baker J, Adamo M, Khan R, George S, Roy M, Rubens M, Ramamoorthy V, Saxena A, Appunni S, McGranaghan P, Jimenez J, Chaparro S.   +12 more
europepmc   +1 more source

Pulmonary Embolism [PDF]

BMJ, 1955
openaire   +2 more sources

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg   +12 more
wiley   +1 more source

QTc Prolongation as a Diagnostic Clue in Acute Pulmonary Embolism. [PDF]

J Clin Med
Sharif S, Kalmanovich E, Marcus G, Tsiporin F, Minha S, Barkagan M, Love I, Fuchs S, Zahavi G, Milman A.   +9 more
europepmc   +1 more source

A CASE OF MINOR ANOMALY TYPE MULTIPLE MYELOMA COMPLICATED WITH PULMONARY EMBOLISM

, 1968
Tadamasa Tozuka, Shozo Kusama, I Mochizuki, Yasuo KURAISHI, Takashi Tanaka, Hidemasa ONO, Kimio Itō, Masamitsu Kanai   +7 more
openalex   +2 more sources